Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Lupus can look like hair loss from alopecia areata but needs different treatment.

Nanotechnology could make hair loss treatments more effective and reduce side effects, but more research is needed before it's available.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

Safflower has been used in traditional medicine for centuries and shows promise in treating heart, brain, and inflammatory conditions, but more research is needed to ensure its safety.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

Some drugs used to treat inflammation may cause hair loss.

Artificial skin is improving wound healing and shows potential for treating different types of wounds.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Erosive pustular dermatosis of the scalp is a type of skin inflammation often confused with other conditions, requiring continuous treatment.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Some skin disorders might be linked to H. pylori infection, but more research is needed to confirm this.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Microneedle technology is beneficial for drug delivery and could make vaccinations cheaper and more accessible.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

The leaves of Platycladus orientalis have potential health benefits but require more research for safety and understanding how they work.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Consider benefits and risks of new alopecia treatments for safety.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.